Name: KTTA Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: KTTA, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does KTTA have?

Accepted Answer

Pasithea Therapeutics Corp. (KTTA) has 6 SEC Form 4 filings (6 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Jun 22, 2026.

Question 2

When was the most recent SEC Form 4 filing for KTTA?

Accepted Answer

The most recent Form 4 filing for KTTA on Tracefour is dated Jun 22, 2026.

Question 3

What is the net insider flow at KTTA over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at KTTA have net bought $53K based on SEC Form 4 disclosures.

Question 4

What is the total insider buy and sell value at KTTA in the current window?

Accepted Answer

Inside the rolling window, insiders at KTTA bought $203K and sold $0 based on SEC Form 4 filings.

Question 5

Can I get alerts for KTTA insider trading?

Accepted Answer

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Pasithea Therapeutics Corp. (KTTA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

						Source
Coastlands Capital LPFirst filing	10% Owner	Purchase	100,000	$53K	Jun 22	SEC ↗
Dumesnil SimonFirst filing	Director	Purchase	33,333	$25K	Dec 1	SEC ↗
Marques TiagoFirst filing	Chief Executive Officer	Purchase	33,333	$25K	Dec 1	SEC ↗
STEINMAN LAWRENCEFirst filing	Director	Purchase	133,333	$100K	Dec 1	SEC ↗

KTTA

Related companies